MedGenome is driven to enable clinicians to deliver the best outcomes to their patients. Our passion to deliver actionable insights to clinicians has resulted in the development of “Claria” - a suite of NGS (Next-Generation Sequencing) technology-based solutions for reproductive testing. Claria offers the most accurate Non-Invasive Prenatal Screening Test (NIPT), the Genetic Carrier Screening Test and the Preimplantation Genetic Screening/Diagnosis (PGS/PGD).
In addition to this Claria now offers not just advanced NGS based tests but also routine prenatal diagnostics and cytogenetic tests
Genetic Counselling: This is a critical support that assists affected and/or at – risk individuals, for themselves and their pregnancy to understand the nature of the genetic disorder, its risk of recurrence and the tests available to them for management & family planning. The cost effectiveness is also discussed. Counselling can be offered for a large spectrum of genetic disorders for individuals in any age group - preconception, prenatal, pediatric and oncology
The tissues generally studied for prenatal diagnosis are chorionic villi, amniotic fluid and cord blood. All prenatal fetal tissue samplings are done as outpatient procedures, under ultrasound guidance. Patient needs to be adequately counselled for the choice, safety, specificity and sensitivity of the test. An informed written consent is a prerequisite. Inhouse facility for the obstetric procedure and sonography is available at the centre.